Nilkanth Engineering Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | -- | -- | -- | -- |
| Op profit growth | -- | -- | -- | -- |
| EBIT growth | -- | -- | -- | -- |
| Net profit growth | -- | -- | -- | -- |
| Profitability ratios (%) | ||||
| OPM | -- | -- | -- | -- |
| EBIT margin | -- | -- | -- | -- |
| Net profit margin | -- | -- | -- | -- |
| RoCE | -- | -- | -- | -- |
| RoNW | -- | -- | -- | -- |
| RoA | -- | -- | -- | -- |
| Per share ratios () | ||||
| EPS | (7.40) | (11) | (16) | -- |
| Dividend per share | -- | -- | -- | -- |
| Cash EPS | -- | -- | -- | -- |
| Book value per share | 877 | 17 | 30.40 | -- |
| Valuation ratios | ||||
| P/E | -- | -- | -- | -- |
| P/CEPS | -- | -- | -- | -- |
| P/B | -- | -- | -- | -- |
| EV/EBIDTA | -- | -- | -- | -- |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | -- | -- | -- | -- |
| Liquidity ratios | ||||
| Debtor days | -- | -- | -- | -- |
| Inventory days | -- | -- | -- | -- |
| Creditor days | -- | -- | -- | -- |
| Leverage ratios | ||||
| Interest coverage | -- | -- | -- | -- |
| Net debt / equity | -- | 9.55 | 13.20 | -- |
| Net debt / op. profit | -- | -- | -- | -- |
| Cost breakup () | ||||
| Material costs | -- | -- | -- | -- |
| Employee costs | -- | -- | -- | -- |
| Other costs | -- | -- | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Revenue | -- | -- | -- | -- |
| yoy growth (%) | -- | -- | -- | -- |
| Raw materials | -- | -- | -- | -- |
| As % of sales | -- | -- | -- | -- |
| Employee costs | -- | -- | -- | -- |
| As % of sales | -- | -- | -- | -- |
| Other costs | -- | -- | -- | -- |
| As % of sales | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- |
| OPM | -- | -- | -- | -- |
| Depreciation | -- | -- | -- | -- |
| Interest expense | -- | -- | -- | -- |
| Other income | -- | -- | -- | -- |
| Profit before tax | -- | -- | -- | -- |
| Taxes | -- | -- | -- | -- |
| Tax rate | -- | -- | -- | -- |
| Minorities and other | -- | -- | -- | -- |
| Adj. profit | -- | -- | -- | -- |
| Exceptional items | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- |
| yoy growth (%) | -- | -- | -- | -- |
| NPM | -- | -- | -- | -- |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Profit before tax | -- | -- | -- | -- |
| Depreciation | -- | -- | -- | -- |
| Tax paid | -- | -- | -- | -- |
| Working capital | (65) | -- | -- | -- |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | (65) | -- | -- | -- |
| Capital expenditure | 0.01 | -- | -- | -- |
| Free cash flow | (65) | -- | -- | -- |
| Equity raised | 110 | 1.74 | -- | -- |
| Investments | 109 | -- | -- | -- |
| Debt financing/disposal | 50 | 42 | -- | -- |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 204 | 43.70 | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Equity capital | 1.25 | 1.25 | 1.25 | 1.25 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 108 | 223 | 0.87 | 2.54 |
| Net worth | 109 | 225 | 2.12 | 3.79 |
| Minority interest | ||||
| Debt | -- | 0.32 | 21 | 50 |
| Deferred tax liabilities (net) | -- | -- | -- | -- |
| Total liabilities | 109 | 225 | 23.10 | 53.80 |
| Fixed assets | 7.80 | 8.67 | 9.77 | 11.20 |
| Intangible assets | ||||
| Investments | 116 | 230 | 6.31 | 7.06 |
| Deferred tax asset (net) | -- | -- | -- | -- |
| Net working capital | (15) | (14) | 6.28 | 35.50 |
| Inventories | -- | -- | -- | -- |
| Inventory Days | -- | -- | -- | -- |
| Sundry debtors | -- | -- | -- | -- |
| Debtor days | -- | -- | -- | -- |
| Other current assets | 0.52 | 0.85 | 21.40 | 50.50 |
| Sundry creditors | -- | -- | -- | -- |
| Creditor days | -- | -- | -- | -- |
| Other current liabilities | (15) | (15) | (15) | (15) |
| Cash | 0.19 | 0.16 | 0.76 | 0.04 |
| Total assets | 109 | 225 | 23.10 | 53.80 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Dec-2020 | Sep-2020 | Jun-2020 | Mar-2020 | Dec-2019 |
|---|---|---|---|---|---|
| Gross Sales | -- | -- | -- | -- | -- |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | -- | -- | -- | -- | -- |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 0.45 | 0.84 | 0.48 | 0.04 | 0.03 |
| Total Income | 0.45 | 0.84 | 0.48 | 0.04 | 0.03 |
| Total Expenditure ** | 0.05 | 0.08 | 0.05 | 0.02 | 0.25 |
| PBIDT | 0.40 | 0.76 | 0.44 | 0.03 | (0.20) |
| Interest | -- | -- | -- | -- | -- |
| PBDT | 0.40 | 0.76 | 0.44 | 0.03 | (0.20) |
| Depreciation | 0.18 | 0.18 | 0.18 | 0.22 | 0.22 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- |
| Deferred Tax | -- | -- | -- | -- | -- |
| Reported Profit After Tax | 0.22 | 0.58 | 0.26 | (0.20) | (0.40) |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | 0.22 | 0.58 | 0.26 | (0.20) | (0.40) |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | 0.22 | 0.58 | 0.26 | (0.20) | (0.40) |
| EPS (Unit Curr.) | 1.80 | 4.68 | 2.09 | -- | (3.60) |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | -- | -- | -- | -- | -- |
| PBDTM(%) | -- | -- | -- | -- | -- |
| PATM(%) | -- | -- | -- | -- | -- |
